YOUR BUSINESS AUTHORITY
Springfield, MO
Drugmakers Mallinckrodt and Endo are set to combine.
The companies reached a cash-and-stock deal valued at $6.7 billion. Endo shareholders will receive $80 million in cash and own nearly 50% of the combined company. Mallinckrodt shareholders would own the remainder.
Mallinckrodt CEO Siggi Olafsson will lead the combined operation.
Read more from The Associated Press.
Organizers hope to bolster client traffic to center city businesses.
AI expert gives advice at SBJ's People You Need to Know
European-style Christmas market to make debut in Branson next week
Big Cedar Lodge golf courses place on Golfweek list
Original, historic Pipkin building up for sale
Pizza Hut co-founder Dan Carney dies
Annual downtown holiday events combine for Nov. 21 celebration